In modern times, the use of herbal products has significantly increased in the developed countries as well as in several other countries. According to a World Health Organization estimate, 80% of the world's population presently uses herbal medicine for some aspect of primary health care [1]. Many of the species are used in traditional medicines for the treatment of a variety of diseases [2]. During the past several years, there has been an increase in the incidence of fungal infections due to the rise in immunocompromised population (e.g., organ transplant recipients and patients with cancer or human immunodeficiency virus infection/acquired immune deficiency syndrome). This fact coupled with the resistance to antibiotics and with toxicity during prolonged treatment with several antifungal drugs has been the reason for an extended search for newer drugs to treat opportunistic fungal infections. Infectious diseases, particularly skin and mucosal infections, are common in most of the tribal inhabitants due to lack of sanitation, potable water, and awareness of hygienic food habits. An important group of these skin pathogens is the fungi, among which dermatophytes and Candida spp. are prominent. Antimicrobial properties of certain Indian medicinal plants were reported based on folklore information and few studies were carried out on the inhibitory activity of these plants against certain pathogenic fungi [3].